Ibuprofen API Market Outlook 2025: Supply Chain & Pricing Trends
According to a newly published market research report by 24LifeSciences, global ibuprofen market was valued at USD 3.87 billion in 2024 and is projected to reach USD 4.98 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.7% during the forecast period 2025–2031.
Ibuprofen, a leading nonsteroidal anti-inflammatory drug (NSAID), is globally recognized for its potent analgesic, antipyretic, and anti-inflammatory properties. As an Active Pharmaceutical Ingredient (API), it serves as the foundational component in numerous over-the-counter and prescription medications designed to treat common conditions such as headaches, muscle pain, arthritis, dental pain, and fever. Its established efficacy and favorable safety profile at recommended doses continue to make it a cornerstone of global pain management strategies.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/669buprofen-market-market
According to a newly published market research report by 24LifeSciences, global ibuprofen market was valued at USD 3.87 billion in 2024 and is projected to reach USD 4.98 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.7% during the forecast period 2025–2031.
Ibuprofen, a leading nonsteroidal anti-inflammatory drug (NSAID), is globally recognized for its potent analgesic, antipyretic, and anti-inflammatory properties. As an Active Pharmaceutical Ingredient (API), it serves as the foundational component in numerous over-the-counter and prescription medications designed to treat common conditions such as headaches, muscle pain, arthritis, dental pain, and fever. Its established efficacy and favorable safety profile at recommended doses continue to make it a cornerstone of global pain management strategies.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/669buprofen-market-market
Ibuprofen API Market Outlook 2025: Supply Chain & Pricing Trends
According to a newly published market research report by 24LifeSciences, global ibuprofen market was valued at USD 3.87 billion in 2024 and is projected to reach USD 4.98 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.7% during the forecast period 2025–2031.
Ibuprofen, a leading nonsteroidal anti-inflammatory drug (NSAID), is globally recognized for its potent analgesic, antipyretic, and anti-inflammatory properties. As an Active Pharmaceutical Ingredient (API), it serves as the foundational component in numerous over-the-counter and prescription medications designed to treat common conditions such as headaches, muscle pain, arthritis, dental pain, and fever. Its established efficacy and favorable safety profile at recommended doses continue to make it a cornerstone of global pain management strategies.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/669buprofen-market-market
0 Комментарии
0 Поделились
7 Просмотры
0 предпросмотр